Vadodara, India

Sanjay Poptani

This inventor holds 1 USPTO granted patent. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanjay Poptani. Retrieved from https://idiyas.com/inventor/sanjay-poptani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sanjay Poptani: Innovator in Pharmaceutical Composition

Introduction

Sanjay Poptani is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceuticals, particularly in the stabilization of drug compositions. His work has implications for improving the efficacy and shelf-life of medications.

Latest Patents

Sanjay holds a patent for a "Linaclotide stable composition." This patent describes a method of stabilizing linaclotide in a solid dosage form, which is crucial for ensuring the drug's effectiveness over time. He has 1 patent to his name, showcasing his innovative approach to pharmaceutical challenges.

Career Highlights

Sanjay Poptani is associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role in the company allows him to work on cutting-edge research and development projects that aim to enhance drug formulations and delivery systems.

Collaborations

Throughout his career, Sanjay has collaborated with talented professionals, including Rajamannar Thennati and Shirish Kulkarni. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Sanjay Poptani's contributions to pharmaceutical innovations, particularly in stabilizing drug compositions, highlight his role as a key inventor in the industry. His work not only advances scientific knowledge but also improves patient care through better medication formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…